Evidence map›Paper›PMID 9234725›Full record

ArticleMolecular and cellular biology1997

Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity.

F Saatcioglu, G Lopez, B L West, E Zandi, W Feng, H Lu, A Esmaili, J W Apriletti, P J Kushner, J D Baxter and 1 more

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. General molecular biology and architecture of nuclear receptors.Current topics in medicinal chemistry · 2012
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

F SaatciogluDepartment of Pharmacology, Center for Molecular Genetics, School of Medicine, University of California at San Diego, La Jolla 92093-0636, USA.
G Lopez
B L West
E Zandi
W Feng
H Lu
A Esmaili
J W Apriletti
P J Kushner
J D Baxter
M Karin
University of California, San Francisco · USUniversity of California San Diego · USUniversity of Oslo · NO

Funding

XRAY CRYSTALLOGRAPHIC STRUCTURE ANALYSIS: PROTEIN SORTINGP41RR001081 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BABBITT, PATRICIA CLEMENT · 1985 to 2011
$17.6M
TRANSFERRING MECHANISMS AND BIOCHEMICAL REGULATION OF E2A-PBX1P01CA050528 · NCI · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI FERAMISCO, JAMES R · 1989 to 1997
–
NCI NIH HHS CA50528NCRR NIH HHS P41-RR01081
6 · The paper itself

Abstract

A short C-terminal sequence that is deleted in the v-ErbA oncoprotein and conserved in members of the nuclear receptor superfamily is required for normal biological function of its normal cellular counterpart, the thyroid hormone receptor alpha (T3R alpha). We carried out an extensive mutational analysis of this region based on the crystal structure of the hormone-bound ligand binding domain of T3R alpha. Mutagenesis of Leu398 or Glu401, which are surface exposed according to the crystal structure, completely blocks or significantly impairs T3-dependent transcriptional activation but does not affect or only partially diminishes interference with AP-1 activity. These are the first mutations that clearly dissociate these activities for T3R alpha. Substitution of Leu400, which is also surface exposed, does not affect interference with AP-1 activity and only partially diminishes T3-dependent transactivation. None of the mutations affect ligand-independent transactivation, consistent with previous findings that this activity is mediated by the N-terminal domain of T3R alpha. The loss of ligand-dependent transactivation for some mutants can largely be reversed in the presence of GRIP1, which acts as a strong ligand-dependent coactivator for wild-type T3R alpha. There is excellent correlation between T3-dependent in vitro association of GRIP1 with T3R alpha mutants and their ability to support T3-dependent transcriptional activation. Therefore, GRIP1, previously found to interact with the glucocorticoid, estrogen, and androgen receptors, may also have a role in T3R alpha-mediated ligand-dependent transcriptional activation. When fused to a heterologous DNA binding domain, that of the yeast transactivator GAL4, the conserved C terminus of T3R alpha functions as a strong ligand-independent activator in both mammalian and yeast cells. However, point mutations within this region have drastically different effects on these activities compared to their effect on the full-length T3R alpha. We conclude that the C-terminal conserved region contains a recognition surface for GRIP1 or a similar coactivator that facilitates its interaction with the basal transcriptional apparatus. While important for ligand-dependent transactivation, this interaction surface is not directly involved in transrepression of AP-1 activity.

Indexed as

MutationSaccharomyces cerevisiae ProteinsAmino Acid SequenceAnimalsConserved SequenceCOS CellsDNA-Binding ProteinsHeLa CellsHumansLigandsModels, MolecularNuclear Receptor Coactivator 2Protein ConformationReceptors, Thyroid HormoneRecombinant Fusion ProteinsTranscriptional ActivationDNA-Binding ProteinsGAL4 protein, S cerevisiaeLigandsNCOA2 protein, humanNuclear Receptor Coactivator 2Receptors, Thyroid HormoneRecombinant Fusion ProteinsSaccharomyces cerevisiae ProteinsTranscription Factor AP-1Transcription FactorsTriiodothyronine

Identifiers

PMID9234725
PMCPMC232321
OpenAlexW2140663666

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.